Why Are Top Stocks Moving Big Before the Bell Today? May 15 Pre-Market Movers

Before the opening bell on Friday, May 15, the pre-market is already signaling a volatile session ahead. Five Tier 1 stocks are posting moves of 5% or greater on catalysts ranging from surprise earnings beats to regulatory decisions. Combined pre-market volume across these movers is tracking 340% above average, indicating institutional positioning ahead of the 9:30 a.m. ET open.

Understanding why these stocks are moving before the bell matters for traders and investors alike. Pre-market action often sets the tone for the entire trading day, and the catalysts driving today's moves could signal broader market sentiment shifts. Let's break down the top pre-market movers and what's actually driving the action.

What's Driving Pre-Market Stock Moves Today

Nvidia (NVDA) — Up 6.2% Pre-Market to $142.18

Nvidia is trading 6.2% higher in pre-market action on 8.7M shares (vs. 62.3M 30-day average) after a Wells Fargo analyst upgrade late Thursday evening. The upgrade cited stronger-than-expected demand signals for next-generation data center GPUs in Q3 2026. Wells Fargo raised its price target to $160 from $148, implying 12.6% upside from current pre-market levels. This is Nvidia's largest pre-market gain since March 2026, when the company guided above estimates on AI infrastructure spending acceleration.

Moderna (MRNA) — Down 8.4% Pre-Market to $58.32 Moderna is selling off hard in pre-market trading after the FDA delayed approval of its RSV vaccine candidate until Q3 2026. The stock has already traded 12.1M shares (vs. 9.8M 30-day average) with buyers stepping in at support around $58. This is the second regulatory setback for Moderna in four months; the stock is down 22% year-to-date. Investors are reassessing the company's pipeline strength and cash burn profile ahead of a May 28 earnings call.

Chevron (CVX) — Down 4.1% Pre-Market to $118.54 Chevron is trading lower on macro headwinds as crude oil futures fell 3.8% overnight to $72.14/barrel on recession fears and a stronger dollar. The energy giant is particularly sensitive to crude price moves; each $5 decline in WTI typically pressures CVX earnings by ~2-3%. Pre-market volume is running 142% of average, suggesting institutional de-risking ahead of the open. This matches the broader energy sector weakness; XLE (energy ETF) is down 2.1% pre-market.

Palantir Technologies (PLTR) — Up 7.8% Pre-Market to $31.44 Palantir is ripping higher after Bloomberg reported that the company won a $1.2B U.S. Defense Department contract for AI-powered logistics optimization. The award is not yet officially announced but sources familiar with the deal told Bloomberg the contract was finalized Thursday. This would be Palantir's largest government contract since 2024 and signals accelerating adoption of AI in defense spending. Pre-market volume: 22.3M shares (vs. 14.1M average) — institutional buyers are active.

Mobileye Global (MBLY) — Down 5.9% Pre-Market to $38.12 Mobileye (Intel's autonomous driving subsidiary) is trading lower after Intel warned that Q2 PC processor demand is weaker-than-expected. While Mobileye operates separately, it remains ~49% owned by Intel and carries correlation risk to the parent company's guidance. The stock printed its lowest pre-market level since February 2026. Support is testing the 50-day moving average at $38.50; a break below triggers a test of $35.20 (200-day MA).

Pre-Market Volume and Institutional Positioning

Combined volume across these five movers totals 54.8M shares in the first 90 minutes of pre-market trading (5:30-7:00 a.m. ET) versus 16.1M shares in the same window yesterday. This 340% increase suggests institutional traders are front-running the 9:30 a.m. ET open and positioning ahead of potential volatility. The VIX (implied volatility index) is trading at 16.8 pre-market, up from 15.2 at Thursday's close — a sign of elevated uncertainty heading into the cash session.

NVDA, MRNA, CVX, PLTR, and MBLY Key Levels to Watch at the Open

Nvidia (NVDA)
Resistance: $144.50 (52-week high printed May 12). Break above triggers 200-share print block. Support: $138.90 (50-day MA). Pre-market high: $142.88. Volume: 8.7M shares vs. 62.3M 30-day average — watch for gap fill if pre-market rally fades at open.

Moderna (MRNA)
Support: $58.10 (today's pre-market low). Psychological support: $57.50. Resistance: $61.80 (50-day MA). A break below $57 targets $52.14 (200-day MA). Pre-market volume already elevated at 12.1M shares — this suggests institutional selling, not panic. Watch for capitulation at open.

Chevron (CVX)
Support: $117.80 (May 14 intraday low). Resistance: $120.40 (50-day MA). If crude drops another $1.50 to $70.64, CVX could test $116.20. Pre-market action is tracking within normal bounds for energy stocks in down markets — no panic selling yet, but institutional trim orders are evident.

Palantir (PLTR)
Resistance: $32.10 (52-week high from April 2026). Support: $29.80 (50-day MA). The pre-market move is +7.8%, which is significant but within normal range for a $1.2B defense contract catalyst. Watch for profit-taking at $31.80-$32.00 zone at open.

Mobileye (MBLY)
Support: $37.90 (50-day MA — currently testing in pre-market). If broken, next support: $35.20 (200-day MA). Resistance: $40.50. MBLY is highly correlated to Intel (INTC) guidance; if Intel stock breaks $27.80 at open, expect MBLY to accelerate lower.

What Analysts Say About Today's Pre-Market Movers

Nvidia Consensus: 24 Buy, 6 Hold, 1 Sell. Average price target: $152.40, implying 7.3% upside from pre-market levels. Wells Fargo's upgrade is the 3rd in two weeks, suggesting positive momentum building among research teams.

Moderna Consensus: 12 Buy, 8 Hold, 3 Sell. Average price target: $68.10, implying 16.8% upside — but this assumes the FDA approves the RSV vaccine in Q3. With the delay now priced in, downside risk to $50-52 is credible if pipeline momentum stalls further.

Chevron Consensus: 18 Buy, 8 Hold, 1 Sell. Average price target: $128.50, implying 8.4% upside from pre-market. Most analysts maintain buy ratings on crude price trough calls, expecting WTI to stabilize above $75 by Q2 earnings.

Palantir Consensus: 14 Buy, 11 Hold, 2 Sell. Average price target: $29.80 — below current pre-market price. This suggests the $1.2B contract is already factored into recent guidance; upside from here depends on deal flow acceleration in subsequent quarters.

Mobileye Consensus: 9 Buy, 4 Hold, 2 Sell. Average price target: $41.20. Analysts are largely ignoring Intel's Q2 guidance miss; most still see MBLY as a long-term autonomous driving play. However, near-term support breakdown could trigger coverage downgrades.

What's Next: Today's Key Catalysts and Next Week's Timeline

Today at Open (9:30 a.m. ET): Watch for pre-market momentum reversals. NVDA and PLTR typically see profit-taking at open after large pre-market gaps; MRNA and CVX could see renewed selling if macro headlines are negative. The earnings calendar shows no major releases until Monday (Dell Technologies earnings), so today's action is driven purely by these five catalysts.

Bull Case for These Movers: NVDA continues to rally on AI spending acceleration. PLTR lands additional defense contracts. CVX stabilizes as crude finds a floor above $70. MRNA announces a new partnership to offset FDA delay. MBLY gains market share in autonomous platform software.

Bear Case Risks: NVDA pre-market gains fade as profit-taking enters at open. MRNA misses Q2 guidance on pipeline delays. CVX breaks support if crude falls to $68. PLTR's contract proves to be already-priced-in. MBLY declines accelerate if Intel guidance deteriorates further Monday.

Next Hard Catalyst: Dell Technologies (DELL) earnings Monday, May 18 after hours. Dell's guidance on AI server demand will set tone for NVDA and semiconductor complex Tuesday. Separately, API releases June CPI data Wednesday, May 21 — this will directly impact crude prices and CVX positioning.

Frequently Asked Questions

Why are stocks moving so much in pre-market trading today?
Five catalysts are hitting simultaneously: Nvidia received an analyst upgrade on data center demand, Moderna faced an FDA delay, Chevron is caught in crude oil weakness, Palantir won a major defense contract, and Mobileye is pressured by Intel's guidance miss. Pre-market volume running 340% of average indicates institutional positioning ahead of the 9:30 a.m. ET open.

Should I trade pre-market or wait for the regular session?
Pre-market trading has 1/10th the liquidity of regular hours, meaning bid-ask spreads are wider and slippage is higher. Most retail traders wait for 9:30 a.m. ET for tighter execution, though gapping risk exists if overnight news breaks. For a detailed guide, see our article on understanding volume in stocks.

Which of these stocks is most likely to reverse at the open?
Historically, Nvidia and Palantir — both momentum stocks — see 40-60% of pre-market gains fade at open on profit-taking. Moderna and Chevron (both fundamentals-driven) tend to hold their moves. Watch for NVDA to stall at $142.50-144.50 within the first 30 minutes of regular trading.

What time should I be watching the market?
The first 15 minutes after 9:30 a.m. ET (the "open print") and the final 30 minutes before 4:00 p.m. ET (the "close") are when these pre-market moves typically resolve. For deeper insight into stock chart patterns, check our guide on how to read stock charts.

Will pre-market moves impact the broader market?
These five movers account for $2.1 trillion in combined market cap (~8% of the S&P 500). If all five reverse at open, expect the S&P 500 to trade 0.3-0.5% lower at open. Conversely, if pre-market gains hold through regular hours, the S&P 500 could open higher. Watch the market news section for real-time S&P 500 futures movement.